Juniper Genomics raises $4.6M in seed funding to advance its whole-genome embryo screening test, led by Company Ventures with participation from several other investors.
Amount Raised
$4.6 Million
Round Type
Seed
TorontoBiotechnologyHealth CareInvestors
Description
Juniper Genomics has launched with $4.6 million in seed funding to commercialize the first embryo screening test using whole genome and transcriptome sequencing. The funding will support commercial expansion, team growth, and ongoing research partnerships. The Canada-based company aims to establish a new clinical standard for IVF genetic testing. Company Ventures led the round, with participation from multiple other investors.
Quick answer
Juniper Genomics raised $4.6 Million in a Seed round, dated June 26, 2025. Investors: Blue Collective, Dria Ventures, Amboy Street Ventures, MBX Capital, Innospark Ventures and Company Ventures. Juniper Genomics is based in Toronto, Ontario, Canada.
- How much did Juniper Genomics raise?
- Juniper Genomics raised $4.6 Million in a Seed round on June 26, 2025.
- Who invested in Juniper Genomics?
- Blue Collective, Dria Ventures, Amboy Street Ventures, MBX Capital, Innospark Ventures and Company Ventures are named as investors in this round.
- What does Juniper Genomics do?
- Juniper Genomics is a Canada-based company that has developed the first embryo screening test utilizing whole genome and transcriptome sequencing.
- Where is Juniper Genomics based and how big is it?
- Juniper Genomics is based in Toronto, Ontario, Canada.
- Who are the decision-makers at Juniper Genomics?
- Fundz holds 1 contact at Juniper Genomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Juniper Genomics that raised within 45 days of this round, from Fundz verified event records.
- Apreo Health raised $130M (Series B) on August 7, 2025.
- Tevogen Inc. raised $1M (Funding Round) on August 7, 2025.
- SNIPR Biome raised $41M (Series B) on August 7, 2025.
- Altera Biosciences raised $1.6M (Pre-Seed) on August 7, 2025.
- Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
- Lysoway Therapeutics raised $2.9M (Seed) on August 6, 2025.
Who to call at Juniper Genomics, and when
A new round usually means Juniper Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Juniper Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Juniper Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Juniper Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Juniper Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Juniper Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.